Outcome of community-acquired pneumonia: Influence of age, residence status and antimicrobial treatment

European Respiratory Journal

Volumn 32, Issue 1, 2008, Pages 139-146

  Kothe, H ^a   Bauer, T ^b   Marre, R ^d   Suttorp, N ^c   Welte, T ^e   Dalhoff, K ^a   Lode, H ^b   Schmidt Ioanas, M ^b   Kuhnke, A ^c   Becker, M ^c   Schlosser, B ^f   Marchel, E ^f   Pletz, M ^e   Beiring, C ^a   Schuebel, N ^a   Lorenz, J ^g   Huntemann, I ^g   Klante, T ^h   Schaberg, T ⁱ   Voigt, K ⁱ   Hetzel, M ^d   Lepper, P M ^d   Jany, B ^j   Ziegler, U ^j   Weber, M ^k   Illmann, T ^k   Wallner, M ^k   Von Baum, H ^l   Gonschior, S ^l   Richter, K ^l   Schweiger, B ^l   more..

^a UNIVERSITY OF LÜBECK   (Germany)

^b HELIOS Emil Von Behring Clinic   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g Lüdenscheid Medical Centre   (Germany)

^h OTTO VON GUERICKE UNIVERSITY   (Germany)

ⁱ Diakoniekrankenhaus   (Germany)

^j Missionsarztliche Klinik   (Germany)

^k CAPNETZ Central Service Unit   (Germany)

^l ROBERT KOCH INSTITUTE   (Germany)

more..

Author keywords

Community acquired pneumonia; Elderly; Nursing home; Outcome; Treatment failure

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD CULTURE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; ELDERLY CARE; FEMALE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; INFLUENZA VIRUS A; LEGIONELLA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOPLASMA PNEUMONIAE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE; AGE; CLINICAL TRIAL; COMMUNICABLE DISEASE; CROSS INFECTION; GERMANY; HOME FOR THE AGED; MIDDLE AGED; MULTICENTER STUDY; NURSING HOME; PNEUMONIA; PROSPECTIVE STUDY;

AGE FACTORS; AGED; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; GERMANY; HOMES FOR THE AGED; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; PNEUMONIA; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 52749090377     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00092507     Document Type: Article

References (41)

1. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20: 820-837.
2. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med 1985; 78: 32-37.
3. European Respiratory Society/European Lung Foundation. Major respiratory diseases: pneumonia. In: Loddenkemper R, Gibson GJ, Sibille Y, eds. European Lung White Book. The First Comprehensive Survey on Respiratory Health in Europe. Sheffield, European Respiratory Society Journals, 2003; pp. 55-64.
4. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159: 2562-2572.
5. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001; 18: 362-368.
6. Riquelme R, Torres A, el-Ebiary M, et al. Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am J Respir Crit Care Med 1997; 156: 1908-1914.
7. Zalacain R, Torres A, Celis R, et al. Community-acquired pneumonia in the elderly: Spanish multicentre study. Eur Respir J 2003; 21: 294-302.
8. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51: 3568-3573.
9. Carratalà J, Mykietiuk A, Fernández-Sabé N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167: 1393-1399.
10. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128: 3854-3862.
11. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002; 165: 766-772.
12. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989; 11: 586-599.
13. Mortensen EM, Coley CM, Singer DE, et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 2002; 162: 1059-1064.
14. Luna CM, Aruj P, Niederman MS, et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006; 27: 158-164.
15. Rello J, Bodi M, Mariscal D, et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 2003; 123: 174-180.
16. Rosón B, Carratalà J, Fernández-Sabé N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 2004; 164: 502-508.
17. CompetenceNetwork for Community-Acquired Pneumonia. Kompetenznetz Ambulant Erworbene Pneumonie. [Competence Network for Community-Acquired Pneumonia.] www.capnetz.de Date last accessed: May 12, 2008.
18. Welte T, Suttorp N, Marre R. CAPNETZ-community-acquired pneumonia competence network. Infection 2004; 32: 234-238.
19. Newcombe RG. Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med 1998; 17: 2635-2650.
20. Fujitani S, Yu VL. A new category-healthcare-associated pneumonia: a good idea, but problems with its execution. Eur J Clin Microbiol Infect Dis 2006; 25: 627-631.
21. Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 2005; 127: 1260-1270.
22. Meyer KC. Aging. Proc Am Thorac Soc 2005; 2: 433-439.
23. Bauer TT, Ewig S, Marre R, Suttorp N, Welte T, CAPNETZ study group. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006; 260: 93-101.
24. Metersky ML, Ma A, Bratzler DW, Houck PM. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169: 342-347.
25. Menéndez R, Torres A, Zalacain R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004; 59: 960-965.
26. Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to Gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 2002; 162: 1849-1858.
27. Torres A, Dorca J, Zalacain R, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med 1996; 154: 1456-1461.
28. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
29. Rello J, Rodriguez A, Torres A, et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 2006; 27: 1210-1216.
30. Salive ME, Satterfield S, Ostfeld AM, Wallace RB, Havlik RJ. Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adults. Public Health Rep 1993; 108: 314-322.
31. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med 2001; 163: 1730-1754.
32. Yakovlev SV, Stratchounski LS, Woods GL, et al. Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit. Eur J Clin Microbiol Infect Dis 2006; 25: 633-641.
33. El Solh AA, Brewer T, Okada M, Bashir O, Gough M. Indicators of recurrent hospitalization for pneumonia in the elderly. J Am Geriatr Soc 2004; 52: 2010-2015.
34. Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999; 160: 397-405.
35. Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med 2000; 162: 154-160.
36. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278: 2080-2084.
37. Capelastegui A, Espana PP, Quintana JM, et al. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. Clin Infect Dis 2004; 39: 955-963.
38. Siegel RE, Halpern NA, Almenoff PL, Lee A, Cashin R, Greene JG. A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia. The optimal duration of therapy. Chest 1996; 110: 965-971.
39. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000; 283: 749-755.
40. Welte T, Petermann W, Schürmann D, Bauer TT, Reimnitz P, MOXIRAPID Study Group. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy. Clin Infect Dis 2005; 41: 1697-1705.
41. Anzueto A, Niederman MS, Pearle J, et al. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clin Infect Dis 2006; 42: 73-81.